loading
Madrigal Pharmaceuticals Inc stock is traded at $428.69, with a volume of 474.21K. It is down -0.08% in the last 24 hours and down -3.22% over the past month. Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
See More
Previous Close:
$429.18
Open:
$427.07
24h Volume:
474.21K
Relative Volume:
1.34
Market Cap:
$9.53B
Revenue:
-
Net Income/Loss:
$-518.67M
P/E Ratio:
-17.07
EPS:
-25.12
Net Cash Flow:
$-438.32M
1W Performance:
+3.10%
1M Performance:
-3.22%
6M Performance:
+25.83%
1Y Performance:
+96.90%
1-Day Range:
Value
$393.61
$434.48
1-Week Range:
Value
$393.61
$436.84
52-Week Range:
Value
$213.71
$463.62

Madrigal Pharmaceuticals Inc Stock (MDGL) Company Profile

Name
Name
Madrigal Pharmaceuticals Inc
Name
Phone
404-380-9263
Name
Address
200 BARR HARBOR DRIVE, SUITE 400, WEST CONSHOHOCKEN, PA
Name
Employee
528
Name
Twitter
@MadrigalPharma
Name
Next Earnings Date
2024-10-31
Name
Latest SEC Filings
Name
MDGL's Discussions on Twitter

Compare MDGL with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
MDGL
Madrigal Pharmaceuticals Inc
429.00 9.57B 0 -518.67M -438.32M -25.12
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
420.72 108.30B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
653.36 69.37B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
480.46 62.38B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
832.19 51.50B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
164.99 34.94B 398.11M -1.03B -868.57M -5.7032

Madrigal Pharmaceuticals Inc Stock (MDGL) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-15-25 Initiated Truist Buy
Sep-04-25 Resumed H.C. Wainwright Buy
Feb-28-25 Upgrade B. Riley Securities Neutral → Buy
Feb-27-25 Reiterated H.C. Wainwright Buy
Jun-28-24 Initiated Cantor Fitzgerald Neutral
Jun-11-24 Initiated Wolfe Research Outperform
Apr-22-24 Initiated BofA Securities Underperform
Mar-15-24 Upgrade B. Riley Securities Sell → Neutral
Mar-06-24 Initiated Citigroup Buy
Feb-26-24 Downgrade B. Riley Securities Neutral → Sell
Dec-20-22 Reiterated Oppenheimer Outperform
Dec-19-22 Reiterated H.C. Wainwright Buy
Dec-19-22 Reiterated Piper Sandler Overweight
Dec-19-22 Upgrade Raymond James Underperform → Mkt Perform
Jul-08-22 Downgrade B. Riley Securities Buy → Neutral
Oct-07-21 Initiated Jefferies Buy
Aug-06-21 Upgrade BMO Capital Markets Market Perform → Outperform
May-20-21 Resumed Goldman Buy
Nov-24-20 Resumed Evercore ISI Outperform
Nov-06-20 Reiterated H.C. Wainwright Buy
Jul-31-20 Initiated Piper Sandler Overweight
Jun-05-20 Initiated BMO Capital Markets Market Perform
May-05-20 Initiated Chardan Capital Markets Buy
Jan-30-20 Initiated Canaccord Genuity Buy
Jan-09-20 Upgrade UBS Neutral → Buy
Nov-07-19 Reiterated H.C. Wainwright Buy
Jun-25-19 Initiated Stifel Hold
Jun-10-19 Upgrade B. Riley FBR Neutral → Buy
Feb-28-19 Reiterated H.C. Wainwright Buy
Feb-22-19 Initiated SVB Leerink Outperform
Jan-23-19 Initiated UBS Neutral
Dec-14-18 Initiated Wolfe Research Outperform
Dec-12-18 Initiated B. Riley FBR Neutral
Nov-19-18 Downgrade Raymond James Mkt Perform → Underperform
Nov-16-18 Upgrade Evercore ISI In-line → Outperform
Sep-04-18 Initiated Citigroup Buy
Aug-06-18 Downgrade Goldman Buy → Neutral
Jun-28-18 Initiated Raymond James Mkt Perform
View All

Madrigal Pharmaceuticals Inc Stock (MDGL) Latest News

pulisher
07:53 AM

How Madrigal Pharmaceuticals Inc. stock reacts to global recession fearsMarket Activity Summary & Weekly High Return Stock Forecasts - newser.com

07:53 AM
pulisher
04:53 AM

How to escape a deep drawdown in Madrigal Pharmaceuticals Inc.Weekly Gains Report & Community Verified Trade Alerts - newser.com

04:53 AM
pulisher
02:31 AM

Is Madrigal Pharmaceuticals Inc. trending in predictive chart modelsEarnings Trend Report & Technical Buy Zone Confirmation - newser.com

02:31 AM
pulisher
01:47 AM

Can Madrigal Pharmaceuticals Inc. stock hit record highs againPortfolio Performance Summary & Technical Confirmation Trade Alerts - newser.com

01:47 AM
pulisher
Oct 28, 2025

Madrigal Pharmaceuticals Experiences Evaluation Revision Amid Strong Market Performance - Markets Mojo

Oct 28, 2025
pulisher
Oct 28, 2025

Madrigal (MDGL) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance

Oct 28, 2025
pulisher
Oct 28, 2025

Madrigal to Present New Data from the Company’s MASH Program at AASLD’s The Liver Meeting 2025 - The Manila Times

Oct 28, 2025
pulisher
Oct 28, 2025

Madrigal Pharmaceuticals Inc. stock chart pattern explainedJuly 2025 Rallies & Real-Time Market Trend Scan - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Madrigal (NASDAQ: MDGL) to present cirrhosis and real-world Rezdiffra data at AASLD 2025 - Stock Titan

Oct 28, 2025
pulisher
Oct 28, 2025

Will Madrigal Pharmaceuticals Inc. (YDO1) stock keep raising dividendsBond Market & Capital Efficiency Focused Ideas - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

How strong is Madrigal Pharmaceuticals Inc. (YDO1) stock earnings growthMarket Performance Report & Expert Approved Momentum Trade Ideas - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Madrigal Pharmaceuticals Inc. stock trendline breakdownPortfolio Value Summary & Stepwise Trade Execution Plans - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Chart based exit strategy for Madrigal Pharmaceuticals Inc.Quarterly Investment Review & Precise Buy Zone Identification - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

How forex fluctuations impact Madrigal Pharmaceuticals Inc. (YDO1) stockEarnings Trend Report & Daily Technical Stock Forecast Reports - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Statistical indicators supporting Madrigal Pharmaceuticals Inc.’s strengthTrade Signal Summary & Expert Approved Momentum Ideas - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

How to integrate Madrigal Pharmaceuticals Inc. into portfolio analysis toolsMarket Risk Summary & Reliable Intraday Trade Alerts - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

Will Madrigal Pharmaceuticals Inc. (YDO1) stock profit from AI boom2025 Earnings Impact & Daily Chart Pattern Signals - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Is it too late to sell Madrigal Pharmaceuticals Inc.Quarterly Risk Review & Low Drawdown Trading Strategies - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Madrigal Pharmaceuticals set to unveil Q3 2025 financial results on November 4 - Traders Union

Oct 27, 2025
pulisher
Oct 27, 2025

Using RSI to spot recovery in Madrigal Pharmaceuticals Inc.July 2025 Review & Daily Technical Forecast Reports - newser.com

Oct 27, 2025
pulisher
Oct 26, 2025

Is Madrigal Pharmaceuticals Inc a good long term investmentProtective Put Strategies & Unlock Free Weekly Portfolio Checkups - earlytimes.in

Oct 26, 2025
pulisher
Oct 26, 2025

Madrigal Pharmaceuticals: Rezdiffra Commercialization Bode Well For Continued Growth MDGL - Seeking Alpha

Oct 26, 2025

Madrigal Pharmaceuticals Inc Stock (MDGL) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$36.77
price up icon 1.06%
$90.31
price down icon 1.45%
$29.00
price down icon 0.36%
$105.25
price up icon 0.19%
biotechnology ONC
$314.22
price down icon 0.61%
$164.99
price down icon 0.18%
Cap:     |  Volume (24h):